SD Biosensor, Inc (KRX:137310)
10,600
-180 (-1.67%)
Feb 21, 2025, 9:00 AM KST
SD Biosensor Revenue
SD Biosensor had revenue of 170.61B KRW in the quarter ending September 30, 2024, with 12.96% growth. This brings the company's revenue in the last twelve months to 674.07B, down -2.80% year-over-year. In the year 2023, SD Biosensor had annual revenue of 655.68B, down -77.64%.
Revenue (ttm)
674.07B
Revenue Growth
-2.80%
P/S Ratio
1.92
Revenue / Employee
1.17B
Employees
576
Market Cap
1,296.88B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 655.68B | -2,276.32B | -77.64% |
Dec 31, 2022 | 2,932.00B | 2.04B | 0.07% |
Dec 31, 2021 | 2,929.96B | 1,243.80B | 73.76% |
Dec 31, 2020 | 1,686.16B | 1,613.20B | 2,211.01% |
Dec 31, 2019 | 72.96B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,364.39B |
Celltrion | 2,876.25B |
Yuhan | 2,008.84B |
SK Biopharmaceuticals | 511.33B |
SK bioscience | 201.30B |
Hanmi Pharm. | 1,495.50B |
Hanmi Science | 1,283.65B |
Hanall Biopharma | 134.24B |